Physical Exercise & Telephone Follow-up Mediated by Telerehabilitation

Status Recruiting

Clinical Trial Summary

Cardiovascular diseases are the leading cause of death and disability globally, accounting for approximately 31% (17.9 million) of all deaths each year. The COVID-19 pandemic has led to the total suspension of most cardiac rehabilitation programs at the highest peaks of the spread, forcing people not to leave home, enhancing metabolic conditions and generating further complications due to sedentary lifestyle. Physical exercise is an essential component in the rehabilitation of patients with heart failure disease, evidencing improvements in quality of life, functional capacity, in addition to reducing the mortality rate, number of rehospitalizations, and levels of depression. It is necessary to carry out interventions adapted to the needs of patients who have difficulties traveling to health centers, however, some authors report that remotely oriented exercise could present results similar to those of traditional rehabilitation in a center or Therefore, promoting a cardiac telerehabilitation program together with telephone educational follow-up could cause greater improvements compared to other cardiac rehabilitation and telerehabilitation programs. Objective: To determine the effects of a physical exercise program and telephone educational follow-up mediated by cardiac telerehabilitation in patients with heart failure on functional capacity, depression, and health-related quality of life.

Clinical Trial Description

A randomized controlled clinical trial type study will be carried out, in a period of 6 months between the year 2022, in patients with a diagnosis of heart failure who enter a cardiac rehabilitation program in the city of Santiago de Cali, Colombia, linking to the research after the consultation with cardiology in three groups: physical exercise program and conventional educational component with telephone follow-up (Intervention), physical exercise program and conventional educational component mediated by cardiac telerehabilitation, to which measurements of sociodemographic variables and clinical before-after measurements (physiological, paraclinical, anthropometric) functional capacity, quality of life and state of depression. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05761639
Study type	Interventional
Source	Clínica de Occidente S.A
Contact	Juan Ávila, PT
Phone	3013369979
Email	rhcardiopulmonar09@gmail.com
Status	Recruiting
Phase	N/A
Start date	October 15, 2022
Completion date	December 20, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03799133` - Safety and Efficacy of the Gastric Reactance (XL) in Patients Post-operated of Elective Cardiac Surgery	N/A
Not yet recruiting	`NCT04538469` - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Terminated	`NCT02205411` - Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation	N/A
Completed	`NCT02524574` - Tomography Positron Emission Assessment of the Impact of Cardiac Rehabilitation on Coronary Endothelial Function in Cardiac Failure	N/A
Active, not recruiting	`NCT03841084` - Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial	Phase 2
Terminated	`NCT02459054` - Syncardia 50cc TAH-t as a Bridge to Transplant	N/A
Terminated	`NCT02859636` - Pronostic Value of Endothelial Dysfunction in Heart Failure	N/A
Completed	`NCT04599816` - Levosimendan Administration in Pulmonary Hypertension	N/A
Not yet recruiting	`NCT04696523` - Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage	Phase 2
Completed	`NCT03357731` - A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function	Phase 2
Completed	`NCT02331264` - Cardiac Assessment of Patients With Hip Implants	N/A
Terminated	`NCT01921829` - Protocolized Diuretic Strategy in Cardiorenal Failure	Phase 4
Completed	`NCT06197256` - Cardiac Dysfunction in Critically Ill Covid-19 Patients
Recruiting	`NCT03197792` - Perioperative Portal Vein Pulsatility as a Postoperative Prognostic Indicator in Pulmonary Endarterectomy	N/A
Completed	`NCT03515980` - An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function	Phase 1
Completed	`NCT03212898` - Pharmacist Interventions in Rural Elderly Warfarin Patients	N/A
Completed	`NCT03243604` - cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE Study
Completed	`NCT06330103` - Efficacy of AI EF Screening by Using Smartphone Application Recorded PLAX View Cardiac Ultrasound Video Clips	N/A
Completed	`NCT02660385` - Insomnia Self-Management in Heart Failure	N/A
Withdrawn	`NCT02669134` - CRT Improved Clinical Response UK Trial	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Physical Exercise and Telephone Follow-up Mediated by Telerehabilitation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms